載入...
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial
Despite the use of multimodal treatment, survival of esophageal cancer (EC) patients remains poor. One proposed explanation for the relatively poor response to cytotoxic chemotherapy is intratumor heterogeneity. The aim was to establish a statistical model to objectively measure intratumor heterogen...
Na minha lista:
| 發表在: | Dis Esophagus |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7397482/ https://ncbi.nlm.nih.gov/pubmed/32591823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/dote/doaa058 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|